Call for Abstract
Scientific Program
7th International Conference on Predictive, Preventive and Personalized Medicine & Molecular Diagnostics, will be organized around the theme “Comprehensive Overview of What Personalized Medicine Means Today”
Personalized Medicine 2017 is comprised of 17 tracks and 84 sessions designed to offer comprehensive sessions that address current issues in Personalized Medicine 2017.
Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.
Register now for the conference by choosing an appropriate package suitable to you.
Customized solution depends on interspecies contrasts. It is proverbial that little contrasts in hereditary make-up can bring about emotional contrasts because of medications or ailment and societal effect of customized pharmaceutical. To express this in more broad terms in any given complex framework, little changes in beginning conditions can bring about drastically diverse results. In spite of human variability and interspecies variety in different species, nonhuman species are still the essential model for finding out information for personalized solution wellbeing change in Human. We raise doubt about this practice and presume that human-based examination ought to be the essential means for acquiring information about human illnesses and reactions to medicates. Systems in the advancement and use of customized prescription were created for the exact results in personalized drug wellbeing change in Human and Animal Models.
- Track 1-1Personalized medicine in pediatrics
- Track 1-2 Clinical next generation sequencing testing
- Track 1-3Personalized medicine in geriartrics
- Track 1-4Personalized medicine adolcents
- Track 1-5Personalized medicine pregnant women
Life Medicine (LM) is the utilization of way of life mediations in the treatment and administration of infection. LM is turning into the favoured methodology for the counteractive action as well as the treatment of most perpetual sicknesses, including Type-2 Diabetes, Coronary Heart Disease, Hypertension, Obesity, Insulin Resistance Syndrome, Osteoporosis, malignancy prevention. Likewise incorporate Aerobic and Resistance practices for patients with diabetes, Sleep and infection counteractive action, intrinsic inspiration and wellbeing conduct adherence.
- Track 2-1Treatment option for chronic disease
- Track 2-2 Physical activity & cardiovascular disorders: How much is enough?
- Track 2-3Aerobic & resistance exercises for diabetic patients
- Track 2-4Intrinsic motivation and health behaviour adherence
- Track 2-5Psychological stress and disease
- Track 2-6Cancer prevention and pain management
- Track 2-7Practicing pathologists in personalized medicine
Preventive Medicine is honed by all doctors to keep their patients sound. It is additionally an exceptional medicinal claim to fame perceived by the American Board of Medical Specialties (ABMS). Preventive Medicine concentrates on the wellbeing of people, groups, and characterized populaces. It is likewise utilized for the treatment for stoutness, visual impairment. The Epidemiology Division applies research strategies to comprehend the examples and reasons for wellbeing and ailment in the populace and to make an interpretation of this learning into projects intended to avert malady. The division has a long history of inclusion in NIH-supported multi-site, longitudinal partner studies, and its personnel manage numerous specialist started, NIH-supported exploration ventures and trials. Open trust in antibodies is a key to the achievement of vaccination projects worldwide in the period of preventive prescription.
- Track 3-1Predictive testing for diverse medical conditions
- Track 3-2Treating ovarian cancer
- Track 3-3Treatment of cardiovascular disease
- Track 3-4Application in metabolic abnormalities
- Track 3-5Neuropsychiatric conditions: Epilepsy
In medication, a biomarker and sub-atomic markers are the quantifiable pointer of the seriousness or vicinity of some infection state. All the more by and large a biomarker is anything that can be utilized as a marker of a specific ailment state or some other physiological condition of a living being Drug-Diagnostic Co-Development. In the present period of stratified solution and biomarker-driven treatments, the centre has moved from forecasts taking into account the conventional anatomic arranging frameworks to direct the decision of treatment for an individual patient to a coordinated methodology utilizing the hereditary cosmetics of the tumour and the genotype of the patient. Genomics and other innovations have to a great extent added to the recognizable proof and the improvement of biomarkers such as Stratification biomarkers in customized pharmaceutical. The late surge in high-throughput sequencing of growth genomes has upheld an extending atomic order of disease. These studies have recognized putative prescient biomarkers meaning unusual oncogene pathway initiation and might give a basis to coordinating patients with molecularly focused on treatments in clinical trials. Here, we examine a percentage of the difficulties of adjusting this information for uncommon growths or atomic subsets of specific tumours, which will require adjusting the accessibility of investigational operators, quick turnaround of clinical evaluation sequencing, sub-atomic qualification and re-examining Personalizing clinical trials with biomarkers outline and end focuses.
- Track 4-1Emerging biomarkers
- Track 4-2Drug diagnostic co-development
- Track 4-3The Microbiome- A modifiable biomarker?
- Track 4-4Biomarkers to clinical diagnostics
- Track 4-5Biomarkers for autoimmune disease
The era of personalized oncology medicine has the potential to fulfil the promise of delivering the right dose for the right indication to the right patient at the right time. Imagine your oncologist knowing before he makes a treatment decision how well your cancer may respond to a particular therapy. Tools that enable a more informed treatment decision do exist and may help individualize your cancer care. It is very important for oncologists to keep updated of the latest advancements in oncology as changes in management of cancer are quite common. All fit patients whose cancer progresses and no standard of care treatment options are available should be enrolled in a clinical trial. Personalized medicine is used to learn about a person’s genetic makeup and how their tumor grows. Using this data, doctors hope to find prevention, screening, and treatment strategies that may be more effective. They also want to find ones that cause fewer side effects than the standard treatments. By performing more genetic tests, doctors may customize treatment to each patient’s needs.
- Track 5-1Diagnosis and staging of Personalized oncology
- Track 5-2Risk factors
- Track 5-3Screening of oncology
Clinical immunology is the study of diseases caused by disorders of the immune system. It also involves diseases of other systems, where immune reactions play a part in the pathology and clinical features. Many components of the immune system are actually cellular in nature and not associated with any specific organ but rather are embedded or circulating in various tissues located throughout the body. Immunotherapy is a new class of cancer treatment that works to harness the innate powers of the immune system to fight cancer. Because of the immune system's unique properties, these therapies may hold greater potential than current treatment approaches to fight cancer more powerfully, to offer longer-term protection against the disease, to come with fewer side effects, and to benefit more patients with more cancer types. Scientists believe that for most people, Alzheimer's disease results from a combination of genetic, lifestyle and environmental factors that affect the brain over time. In Parkinson’s disease, cells that produce dopamine start to die. Dopamine is a chemical that helps you move normally. There is no known direct cause of Parkinson’s. One theory is that it may be hereditary. Other theories say exposure to pesticides and living in rural communities may cause it.
- Track 6-1Clinical immunology
- Track 6-2Alzheimer’s disease
- Track 6-3 Parkinson’s disease
- Track 6-4Cancer immunology
The objective of the Cardiac Research is to quicken interpretation of promising new crucial examination revelations for the treatment of heart disappointment and arrhythmias through very much composed clinical trials that exhibit viability and security. Vascular Medicine envelops a wide range of different disease states. As the field of vascular Medicine develops, the extent of illnesses being dealt with changes. Cardiovascular renovating alludes to the adjustments in size, shape, structure and physiology of the heart after damage to the myocardium. The harm is normally because of intense myocardial dead tissue. To portray the expansion in lipoprotein interpretation by hypothyroidism, adipocytes were readied from control and hypothyroid rats. While LPL combination was higher in hypothyroid adipocytes, with no adjustment in mRNA levels, there was no expansion in hormone-touchy lipase (HSL) blend.
To figure out if an executing interpretation administrative component was available, a cytoplasmic portion was readied from control and hypothyroid adipocytes, and added to an in vitro interpretation framework containing the hLPL mRNA. Clinical results with non-biologic treatment, given ahead of schedule over the span of the ailment, are in the same class as with biologic treatments. Mixes of medicines are normally required to accomplish quick and supported reduction.
- Track 7-1Stem cells in cardiac and vascular regeneration
- Track 7-2Metabolic and lipoprotein translation
- Track 7-3 Angiology
Personalized Medicine is a developing routine of medication that uses an individual's hereditary profile to guide choices made with respect to the counteractive action, determination, and treatment of ailment. Information of a patient's hereditary profile can offer specialists some assistance with selecting the best possible prescription or treatment and manage it utilizing the correct measurement or regimen. Utilized for the treatment as Personalized growth solution, Diabetes-related sickness: hazard appraisal and administration, Personalized pharmaceutical: New procedures and monetary ramifications, Implications of customized prescription in treatment of HIV, Applications of customized drug in uncommon illnesses, Translational Medicine.
- Track 8-1Personalised medicine in healthcare
- Track 8-2Horizons of personalized medicine
- Track 8-3Realizing the value of personalized medicine
- Track 8-4Biobanking: Transforming healthcare
- Track 8-5Drug designing in personalized medicine
- Track 8-6Future of personalized medicine
Personalized Medicine is a developing routine of medication that uses an individual's hereditary profile to guide choices made with respect to the counteractive action, determination, and treatment of ailment. Information of a patient's hereditary profile can offer specialists some assistance with selecting the best possible prescription or treatment and manage it utilizing the correct measurement or regimen. Utilized for the treatment as Personalized growth solution, Diabetes-related sickness: hazard appraisal and administration, Personalized pharmaceutical: New procedures and monetary ramifications, Implications of customized prescription in treatment of HIV, Applications of customized drug in uncommon illnesses, Translational Medicine.
- Track 9-1Therapeutics and diagnostics
- Track 9-2Preclinical and clinical diagnostics
- Track 9-3Translational research
- Track 9-4Liquid biopsy
- Track 9-5Personalized imaging
- Track 9-6Diagnostic assays
P4 Medicine is an arrangement to profoundly enhance the nature of human life by means of biotechnology. P4 Medicine is a term authored by scholar Leroy Hood, and is another way to say "Predictive, Preventive, Personalized Medicine, and Molecular Medicine." The reason of P4 Medicine is that, throughout the following 20 years, restorative practice will be altered by biotechnology, to deal with a man's wellbeing, rather than deal with a patient's infection. Inner solution or general medication (in Commonwealth countries) is the medicinal claim to fame managing the avoidance, determination, and treatment of grown-up maladies. Crisis solution is a medicinal claim to fame including watch over grown-up and paediatric patients with intense sicknesses or wounds that require quick therapeutic consideration.
- Track 10-1Strategic analysis of industry trends
- Track 10-2Companion diagnostic market
- Track 10-3Personalized medicine & targeted therapeutics
- Track 10-4New strategies & economic implications
- Track 11-1Healthcare using pharmacogenomics
- Track 11-2Personalised medicine for cancer
- Track 11-3Personalised medicine for cardiovascular diseases
- Track 11-4Personalised medicine for diabetes
- Track 11-5Personalised medicine for obesity
- Track 11-6Personalised approach in psychological disorders
- Track 11-7Target based personalized therapy
- Track 12-1Implications of personalized medicine in treatment of HIV
- Track 12-2Treatment of neuropsychiatric disorders
- Track 12-3New born screening & prenatal testing
- Track 12-4Applications in treating rare diseases
- Track 12-5Development of personalized genetic medicine
Genetic disorders may or may not be heritable from the parents genes. In non-heritable genetic disorders, defects may be caused by new mutations and changes to the DNA. In such cases, the defect will only be heritable if it occurs in the germ line .Such as some forms of cancer, may be caused by an inherited genetic condition in some people by new mutations in other people, and mainly by environmental causes in other people. Whether, when and to what extent a person with the genetic defect abnormality will actually suffer from the disease is almost always affected by the environmental factors and events in the persons development.
- Track 13-1Molecular diagnostics in genetic disorders
- Track 13-2Biomarkers in genetic disorders
- Track 13-3Personalized treatment of cystic fibrosis
- Track 13-4New era of Proteomics
- Track 13-5Protein microarrays for personalized medicine
- Track 14-1Genomic evaluation by personalized studies
- Track 14-2 Human genome variation
- Track 14-3Biomedical informatics
- Track 14-4Metagenomics & comparative genomics
- Track 14-5Genetics informed personalized immunotherapy
- Track 14-6Data solutions in clinical genomics
- Track 14-7Controlling outburst of mutations
Arrangement investigation of Ebola infection Genome is the second through the 6th qualities of the Ebola infection (EBO) genome demonstrates that it is sorted out also to rhabdoviruses and paramyxoviruses and is for all intents and purposes the same as Marburg infection (MBG). Researchers utilized genomic sequencing advancements to recognize the starting point and track transmission of the Ebola infection in the ebb and flow flare-up in Africa.
- Track 15-1Ebola virus genome
- Track 15-2Genomic sequencing technologies: Identify Ebola virus
- Track 16-1Cell based therapy
- Track 16-2Molecular mechanisms
- Track 16-3Personalized medicine in organ transplantation
- Track 16-4Controlling proliferation
- Track 17-1Contribution towards personalized medicine.
- Track 17-2Significance of pharmaceutical Nano tools
- Track 17-3Nanobioscience: Advance therapy
- Track 17-4Role of metabolomics
- Track 17-5Bioinformatics in personalized medicine
- Track 17-6Biosensors in personalized medicine